quipazine

Quipazine is a non-selective 5-HT receptor agonist. It stimulates central serotonin receptors to induce serotonin syndrome in animal models, utilized for studying behavioral regulation and sleep cycle control.

Quipazine dimaleate is a selective 5-HT3 agonist.

Quipazine maleate is a non-selective 5-HT receptor agonist. It is used to induce serotonin syndrome models and study 5-HT regulated behaviors and physiology.

N-Methylquipazine is an agonist of 5-HT3. It has almost the same affinity for 5-HT3 sites as quipazine.

6-Nitroquipazine (DU24565) is a potent and selective inhibitor of the 5-HT transporter, with a Ki value of 0.17 nM. It is utilized in research related to mental disorders such as depression.

5-HT3 agonist

Seganserin, a non-selective 5-hydroxytryptamine 2-HT receptor antagonist, reversed the inhibitory effects of fluoxetine and quipazine on luteinizing hormone-induced hyperphagia, depression and nociception, and reversed the antidepressant and analgesic effects induced by fluoxetine and quipazine.